NCT03780907View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 14, 2003

Primary Completion Date

August 6, 2003

Study Completion Date

August 6, 2003

Conditions

Epilepsy

Interventions

DRUG

E2007

1 mg of E2007 was administered by mouth once daily.

DRUG

E2007

2 mg of E2007 was administered by mouth once daily.

DRUG

Placebo

Placebo once daily of oral tablet formulation to be taken in the morning, one hour before breakfast, with a glass of water.

Trial Locations (1)

Unknown

3ClinicalResearch AG, Hennigsdorf

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT03780907 - Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy | Biotech Hunter | Biotech Hunter